Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac and formulations of diclofenac that provide both rapid and sustained relief from acute pain. Methods and formulations are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia phonophobia nausea and vomiting.

The present invention relates to a pharmaceutical formulation comprising mannitol and diclofenac or a pharmaceutically acceptable salt thereof in a particulate form at a weight ratio of greater than about 1.5:1.

Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac and formulations of diclofenac that provide both rapid and sustained relief from acute pain. Methods and formulations are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia phonophobia nausea and vomiting.

Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac and formulations of diclofenac that provide both rapid and sustained relief from acute pain. Methods and formulations are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia phonophobia nausea and vomiting.

Se proporcionan métodos y formulaciones para tratar la migraña y otros episodios de dolor agudo usando diclofenac y formulaciones de diclofenac que proporcionan el alivio rápido y sostenido del agudo. También se proporcionan métodos y formulaciones para tratar los síntomas que comúnmente acompañan la migraña y el dolor agudo tales como la fotofobia la fonofobia la náusea y los vómitos.

Se proporcionan métodos y formulaciones para tratar la migrana y otros episodios de dolor agudo usando diclofenac y formulaciones de diclofenac que proporcionan el alivio rápido y sostenido del agudo. También se proporcionan métodos y formulaciones para tratar los síntomas que comunmente acompanan la migrana y el dolor agudo tales como la fotofobia la fonofobia la náusea y los vomitos. Reivindicacion 1: Un método para tratar la migrana asociada con fonofobia o fotofobia en un paciente humano car...

An adhesive transdermal formulation containing a suspension of diclofenac sodium in polyoxyl hydrogenated castor oil a copolymer of aminoalkyl methacrylate and methacrylate one or more crosslinking agents for said copolymer an adhesion system and possibly other excipients.

Formulación farmacéutica de uso oral que contiene diclofenac en sal sódica o potásica junto con bicarbonatos sódicos o potásicos o mezclas de los mismos junto con excipientes y adyuvantes habituales caracterizada porque dichos bicarbonatos sódicos o potásicos están presentes en una cantidad comprendida entre el 20 y el 80 % en peso basado en el peso de diclofenac.